Cardiff Oncology Inc (CRDF)
4.07
+0.08
(+2.00%)
USD |
NASDAQ |
Apr 26, 16:00
4.20
+0.13
(+3.19%)
After-Hours: 20:00
Cardiff Oncology Price to Book Value: 2.620 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 2.556 |
| April 24, 2024 | 2.678 |
| April 23, 2024 | 2.671 |
| April 22, 2024 | 2.793 |
| April 19, 2024 | 2.787 |
| April 18, 2024 | 2.800 |
| April 17, 2024 | 2.883 |
| April 16, 2024 | 2.940 |
| April 15, 2024 | 3.382 |
| April 12, 2024 | 3.594 |
| April 11, 2024 | 3.632 |
| April 10, 2024 | 3.773 |
| April 09, 2024 | 3.626 |
| April 08, 2024 | 3.767 |
| April 05, 2024 | 3.741 |
| April 04, 2024 | 3.632 |
| April 03, 2024 | 3.415 |
| April 02, 2024 | 3.440 |
| April 01, 2024 | 3.671 |
| March 28, 2024 | 3.421 |
| March 27, 2024 | 3.684 |
| March 26, 2024 | 3.453 |
| March 25, 2024 | 3.786 |
| March 22, 2024 | 3.748 |
| March 21, 2024 | 3.293 |
| Date | Value |
|---|---|
| March 20, 2024 | 3.178 |
| March 19, 2024 | 3.120 |
| March 18, 2024 | 3.312 |
| March 15, 2024 | 3.222 |
| March 14, 2024 | 3.459 |
| March 13, 2024 | 3.459 |
| March 12, 2024 | 2.87 |
| March 11, 2024 | 2.588 |
| March 08, 2024 | 2.652 |
| March 07, 2024 | 2.249 |
| March 06, 2024 | 2.492 |
| March 05, 2024 | 2.338 |
| March 04, 2024 | 2.236 |
| March 01, 2024 | 1.864 |
| February 29, 2024 | 1.131 |
| February 28, 2024 | 1.166 |
| February 27, 2024 | 1.140 |
| February 26, 2024 | 1.096 |
| February 23, 2024 | 1.070 |
| February 22, 2024 | 1.083 |
| February 21, 2024 | 1.076 |
| February 20, 2024 | 1.089 |
| February 16, 2024 | 1.108 |
| February 15, 2024 | 1.121 |
| February 14, 2024 | 1.115 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3894
Minimum
May 11 2022
26.04
Maximum
Nov 30 2020
2.687
Average
1.458
Median
Dec 31 2019
Price to Book Value Benchmarks
| BioVie Inc | 2.608 |
| Perspective Therapeutics Inc | 12.41 |
| Biolase Inc | -- |
| Tenon Medical Inc | 3.665 |
| Adial Pharmaceuticals Inc | 1.599 |
Price to Book Value Related Metrics
| PS Ratio | 374.44 |
| PEG Ratio | -0.9785 |
| Price | 4.07 |
| Earnings Yield | -22.74% |
| Market Cap | 182.73M |
| PEGY Ratio | -0.9785 |